Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
US Stock MarketDetailed Quotes
BDRX Biodexa Pharmaceuticals
- 1.460
- -0.030-2.03%
Trading Apr 30 10:15 ET
3.74MMarket Cap-0.11P/E (TTM)
1.485High1.450Low3.09KVolume1.480Open1.490Pre Close4.53KTurnover0.13%Turnover RatioLossP/E (Static)2.56MShares73.99852wk High0.34P/B3.37MFloat Cap1.14052wk Low--Dividend TTM2.31MShs Float14680000.000Historical High--Div YieldTTM2.32%Amplitude1.140Historical Low1.466Avg Price1Lot Size
Biodexa Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | (FY)Dec 31, 2016 | (FY)Dec 31, 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -79.62%-12.26M | 3.15%-6.83M | -17.31%-7.05M | 35.40%-6.01M | -9.3M | |||||
| Net income from continuing operations | 19.07%-5.73M | 7.54%-7.08M | -40.22%-7.66M | 75.39%-5.46M | -120.02%-22.19M | 32.90%-10.09M | 6.44%-15.03M | 20.33%-16.06M | -99.64%-20.16M | -14.48%-10.1M |
| Operating gains losses | -561.86%-3.21M | -6.59%-485K | 53.48%-455K | -275.27%-978K | --558K | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -10.25%254K | -17.49%283K | -14.89%343K | -66.89%403K | --1.22M | ---- | ---- | ---- | ---- | ---- |
| Deferred tax | 38.42%-250K | 51.20%-406K | -28.79%-832K | 49.57%-646K | 28.24%-1.28M | 12.16%-1.79M | -60.63%-2.03M | 86.19%-1.27M | -708.47%-9.16M | -11.30%-1.13M |
| Other non cash items | 95.24%-2K | -275.00%-42K | -45.45%24K | 33.33%44K | -94.02%33K | -5.64%552K | 334.94%585K | 80.30%-249K | 31.71%-1.26M | -1,309.80%-1.85M |
| Change In working capital | -7,524.49%-3.74M | -109.42%-49K | 184.28%520K | 60.40%-617K | -186.65%-1.56M | 223.74%1.8M | -1.11%-1.45M | -1,087.60%-1.44M | 86.42%-121K | -172.62%-891K |
| -Change in receivables | -1,736.99%-5.98M | 5,114.29%365K | 101.44%7K | -198.78%-487K | -32.00%493K | -29.61%725K | 206.40%1.03M | -300.00%-968K | 84.29%-242K | -302.37%-1.54M |
| -Change in inventory | ---- | ---- | ---- | ---- | ---- | ---- | 271.78%347K | 14.77%-202K | -282.26%-237K | ---62K |
| -Change in payables and accrued expense | 1,181.64%2.24M | -158.15%-207K | 373.85%356K | 93.51%-130K | ---2M | ---- | ---- | ---- | ---- | ---- |
| -Change in other working capital | ---- | -231.85%-207K | --157K | ---- | ---47K | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -79.62%-12.26M | 3.15%-6.83M | -17.31%-7.05M | 35.40%-6.01M | -43.33%-9.3M | 51.75%-6.49M | -3.84%-13.45M | 1.02%-12.95M | -5.35%-13.09M | -127.70%-12.42M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -125.66%-598K | -20.45%-265K | 20.86%-220K | -110.80%-278K | 2.57M | |||||
| Net PPE purchase and sale | 59.09%-9K | 47.62%-22K | 84.89%-42K | -321.21%-278K | 78.71%-66K | -41.55%-310K | 69.02%-219K | 47.51%-707K | -46.10%-1.35M | 10.49%-922K |
| Net intangibles purchase and sale | -222.78%-765K | ---237K | --0 | --0 | ---- | ---9K | --0 | -3,994.74%-778K | -533.33%-19K | ---3K |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---947K | ---- | ---- | --0 | -674.78%-661K |
| Net other investing changes | ---- | 61.84%-79K | ---207K | ---- | 203.53%2.64M | -127.53%-2.55M | --9.26M | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -125.66%-598K | -20.45%-265K | 20.86%-220K | -110.80%-278K | 167.61%2.57M | -142.10%-3.81M | 715.10%9.04M | -22.30%-1.47M | 21.59%-1.2M | -69.02%-1.53M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -16.32%8.56M | 21,657.45%10.23M | -99.47%47K | 185.51%8.81M | 3.08M | |||||
| Net issuance payments of debt | 230.32%245K | -5.62%-188K | 17.21%-178K | 96.52%-215K | -260.20%-6.18M | 166.29%3.86M | -224.25%-5.82M | 2,855.88%4.69M | -3.03%-170K | -130.33%-165K |
| Net common stock issuance | -20.28%8.31M | 4,190.95%10.43M | -97.31%243K | -7.26%9.04M | -30.95%9.74M | --14.11M | --0 | --5.73M | ---- | ---- |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | ---- | ---- | ---- | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | ---- | -120.11%-229K | --1.14M | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -16.32%8.56M | 21,657.45%10.23M | -99.47%47K | 185.51%8.81M | -83.54%3.08M | 389.45%18.73M | -162.98%-6.47M | -32.63%10.28M | 7,065.75%15.26M | -100.64%-219K |
| Net cash flow | ||||||||||
| Beginning cash position | 110.54%5.97M | -71.80%2.84M | 33.28%10.06M | -30.95%7.55M | 366.41%10.93M | -82.26%2.34M | -25.01%13.2M | 8.86%17.61M | -46.66%16.18M | 1,170.42%30.33M |
| Current changes in cash | -237.22%-4.3M | 143.42%3.14M | -386.66%-7.22M | 169.15%2.52M | -143.18%-3.64M | 177.55%8.44M | -162.42%-10.88M | -528.75%-4.15M | 106.82%967K | -150.73%-14.17M |
| Effect of exchange rate changes | --0 | --0 | --0 | -103.07%-8K | 76.35%261K | 678.95%148K | 107.36%19K | -155.36%-258K | 1,926.09%466K | --23K |
| End cash Position | -72.05%1.67M | 110.54%5.97M | -71.80%2.84M | 33.28%10.06M | -30.95%7.55M | 366.41%10.93M | -82.26%2.34M | -25.01%13.2M | 8.86%17.61M | -46.66%16.18M |
| Free cash flow | -83.88%-13.04M | 0.30%-7.09M | -12.36%-7.11M | 33.46%-6.33M | -39.69%-9.51M | 50.28%-6.81M | 5.15%-13.69M | 0.10%-14.44M | -8.29%-14.45M | -105.80%-13.35M |
| Currency Unit | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | -- | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | Unqualified Opinion | Unqualified Opinion |
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
